| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e06d8df5ecb58e082a70a2bd8c474836 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2430-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-232
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-412 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-00 |
| filingDate |
1994-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f979a5bd21edff38317a67ce2a0dd515
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1fc401f81366f173aad211434ae832c1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c496536c51a00d50ed451d896595c5a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8fe159e122b2753b044d0d4f353c4b79 |
| publicationDate |
1995-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2165826-A1 |
| titleOfInvention |
Hyaluronic acid fragments and their therapeutic use |
| abstract |
Herein described are therapeutic compositions that contain, as active ingredient, hyaluronic acid fragments that are characterized structurally by a chain length of from 5 to 16 monosaccharides, and by a GlcNAc residue at the non-reducing end. A particularly preferred fragment is the nonameric GlcNAc-[GlcUA-GlcNAc]4. The fragments are useful particularly to effect localized bone repair, such as for the treatment of bone fracture. |
| priorityDate |
1993-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |